Finance

Lists
002275:SHE
Guilin Sanjin Pharmaceutical Co., Ltd.
CNÂ¥12.54
+0.80%
(+0.10) 1D
Aug 28, 3:04:57 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002275...
Open
CNÂ¥12.40
High
CNÂ¥12.68
Low
CNÂ¥12.35
Mkt. cap
7.37B
Avg. vol.
2.66M
Volume
3.19M
Dividend
3.99%
Quarterly dividend
CNÂ¥0.12
Ex-dividend date
Jun 4, 2026
P/E ratio
18.10
52-wk high
CNÂ¥15.75
52-wk low
CNÂ¥11.91
EPS
CNÂ¥0.69
Shares outstanding
587.57M
No. of employees
3K
Open
CNÂ¥12.40
High
CNÂ¥12.68
Low
CNÂ¥12.35
Mkt. cap
7.37B
Avg. vol.
2.66M
Volume
3.19M
Dividend
3.99%
Quarterly dividend
CNÂ¥0.12
Ex-dividend date
Jun 4, 2026
P/E ratio
18.10
52-wk high
CNÂ¥15.75
52-wk low
CNÂ¥11.91
EPS
CNÂ¥0.69
Shares outstanding
587.57M
No. of employees
3K
About Guilin Sanjin Pharmaceutical Co., Ltd.
CEO-
Employees2.56K
FoundedFeb 23, 1994
Headquarters-
SectorPharmaceutical industry
Websitesanjin.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
464.04M
583.35M
525.12M
443.48M
Cost of goods sold
120.09M
146.29M
93.13M
132.66M
Cost of revenue
120.09M
146.29M
93.13M
132.66M
Research and development expenses
30.18M
68.98M
53.24M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
193.59M
270.13M
185.28M
-
Operating expense
231.97M
354.02M
284.20M
-
Total operating expenses
352.07M
500.30M
377.33M
227.11M
Operating income
111.98M
83.04M
147.79M
-
Other non operating income
-1.66M
1.46M
-151.83K
-
EBT including unusual items
127.69M
67.38M
152.08M
161.91M
EBT excluding unusual items
116.86M
74.31M
150.90M
171.28M
Income tax expense
29.29M
19.47M
27.73M
25.60M
Effective tax rate
22.94%
28.90%
18.23%
15.81%
Other operating expenses
6.24M
1.60M
1.07M
-
Net income
98.40M
47.91M
124.36M
136.31M
Net profit margin
21.21%
8.21%
23.68%
30.74%
Earnings per share
-
-
-
-
Interest and investment income
8.43M
6.17M
4.23M
-
Interest expense
-1.89M
-16.71M
-971.70K
-
Net interest expenses
6.53M
-10.54M
3.26M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
134.72M
103.95M
168.69M
238.00M
Gain or loss from assets sale
1.86K
-145.62K
-
-8.06K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps